Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 290
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03850691 | Radiation and Combination Immunotherapy for Melanoma | ||
| NCT01666080 | Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) | ||
| NCT00400803 | Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer | ||
| NCT00775931 | Allogeneic Transplantation For Severe Osteopetrosis | ||
| NCT01451502 | Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units | ||
| NCT01343368 | Preservation of Ovarian Function After Hematopoietic Cell Transplant | ||
| NCT00620295 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | ||
| NCT02582775 | MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs | ||
| NCT00455312 | Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA | ||
| NCT06412497 | MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure. | ||
| NCT03314974 | Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders | ||
| NCT04003805 | Biomarkers of Exposure and Effect in Standardized Research E-cigarette (SREC) Users | ||
| NCT01526603 | High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | ||
| NCT01171469 | Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor | ||
| NCT05114837 | Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL | ||
| NCT00293293 | Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine | ||
| NCT02179359 | Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies | ||
| NCT02991898 | Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies | ||
| NCT00167219 | Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) | ||
| NCT01464359 | T-Cell Depleted Double UCB for Refractory AML | ||
| NCT02118285 | Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT01207076 | AHN-12 Biodistribution in Advanced Leukemia | ||
| NCT01043640 | Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders | ||
| NCT00095160 | Safety Study of an Immune Response Modifier in Patients With Refractory Solid Organ Tumors | ||
| NCT00356941 | Oxaliplatin, Docetaxel, and Radiation Therapy in Treating Patients With Unresectable Stage II/III or Recurrent NSCLC | ||
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | ||
| NCT00623077 | MT2004-30: Tomotherapy for Solid Tumors | ||
| NCT00630565 | Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia | ||
| NCT03297463 | Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma | ||
| NCT00617929 | Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant | ||
| NCT00652899 | Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer | ||
| NCT00303667 | Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | ||
| NCT02118311 | Treg Cells for AGVHD in Non-myeloablative UCB Transplant | ||
| NCT00345865 | Autologous Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | ||
| NCT00818649 | Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia | ||
| NCT02845414 | Study of CD133KDEL Toxin in the Treatment for Solid Tumors | ||
| NCT00176878 | Stem Cell Transplant for Bone Marrow Failure Syndromes | ||
| NCT00855114 | Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery | ||
| NCT03557749 | Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies | ||
| NCT04714372 | FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia | ||
| NCT00643240 | Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia | ||
| NCT02395822 | MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients | ||
| NCT03934840 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | ||
| NCT05735717 | MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies | ||
| NCT03294304 | BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy | ||
| NCT01652092 | Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies | ||
| NCT00625092 | Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies | ||
| NCT06544811 | American Indian Smokefree Native RCT | ||
| NCT01106950 | Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) | ||
| NCT02765997 | StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies |
